(19)
(11) EP 4 816 404 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24896655.8

(22) Date of filing: 28.11.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C12N 15/13(2006.01)
A61K 39/00(2006.01)
A61P 35/00(2006.01)
C07K 19/00(2006.01)
C12N 15/63(2006.01)
A61K 39/395(2006.01)
A61P 31/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/00; A61P 35/00; C07K 16/2818; C07K 2317/622; C07K 2317/20; C07K 2317/76; C07K 2317/92; C07K 2317/53; A61K 2039/505; C07K 2317/90; A61K 40/31; A61K 40/11; A61K 40/4221
(86) International application number:
PCT/CN2024/135314
(87) International publication number:
WO 2025/113570 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 WO PCT/CN2023/135191

(71) Applicant: Vetigenics, Inc.
Philadelphia, PA 19104 (US)

(72) Inventors:
  • SAX, Adriann Weiler
    Philadelphia, PA 19104 (US)
  • LIAO, Shanhui
    Shanghai 201403 (CN)

(74) Representative: Brand Murray Fuller LLP 
First Floor, 111 Wardour Street
London W1F 0UH
London W1F 0UH (GB)

   


(54) FULLY CANINE ANTIBODIES AND USES THEREOF